News

Researchers at Sylvester Comprehensive Cancer Center reveal how body composition analysis predicts treatment response in ...
During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discuss innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, ...
A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and ...
Gene therapy appears to be a promising approach for a subset of genetic deafness, although challenges remain with development ...
As rates of childhood obesity rise, clinicians call for increased data collection to support insurance coverage and safe use of glucagon-like peptide 1 (GLP-1) medications in children under 12 years.
In a large fecal immunochemical test-based screening program, high adenoma detection rates lowered interval colorectal cancer ...
A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal ...
An expert discusses the clinical presentation and diagnosis of immune thrombocytopenic purpura (ITP), emphasizing that ...
An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions ...
On July 2, linvoseltamab-gcpt (Lynozyfic; Regeneron) received an accelerated approval from the FDA in relapsed/refractory ...
Proceeding with hematopoietic stem cell transplantation (HSCT) is more cost-effective than delaying the procedure in patients ...
TACE combined with SBRT enhanced survival rates in patients with large hepatocellular carcinoma tumors, offering promising ...